Title

質子治療在頭頸癌之發展與應用

Translated Titles

Advances and Applications of Proton Beam Therapy in Head and Neck Cancer

DOI

10.6320/FJM.202009_24(5).0007

Authors

王駿瑋(Chun-Wei Wang)

Key Words

質子治療 ; 頭頸癌 ; 放射治療 ; 強度調控 ; proton therapy ; head and neck cancer ; radiotherapy ; intensity-modulation

PublicationName

台灣醫學

Volume or Term/Year and Month of Publication

24卷5期(2020 / 09 / 25)

Page #

542 - 548

Content Language

繁體中文

Chinese Abstract

放射治療在頭頸癌的角色日趨重要,相較於傳統手術方式,放射治療在許多原發性頭頸腫瘤能帶來更好的功能保存性,並改善臨床療效。雖然現今的光子放射治療技術已有大幅進步,但仍會帶來如口乾、吞嚥困難、頸部纖維化、聽力受損及其它相關副作用。相較於光子射束,質子具有重要的「布拉格峰」物理優勢,能進一步降低正常組織之傷害。過去因為建置成本昂貴而一直無法普及,台灣自2017年開始引進質子設備,未來幾年內北、中、南各區將會陸續成立數間質子治療中心。本文章整理過去發表文獻資料,回顧質子治療在頭頸癌的治療成效,亦作為未來台灣質子治療臨床應用之參考。

English Abstract

The role of radiation therapy in head and neck cancer is becoming increasingly important. Radiotherapy, in comparison to surgery, has been shown to be associated with better functional preservation and improved outcomes in many primary head and neck cancers. Though great progress has been made with photon radiotherapy technology, side-effects such as xerostomia, dysphagia, fibrosis in the neck, hearing loss, and many other related toxicities are continuously reported with radiotherapy. Compared with traditional photon beams, proton therapy offers an advantage of the "Bragg peak," thus, allowing precise localization of the radiation, eliminating the exit dose, and sparing normal cells; however, the high cost of construction has prevented the popularization of proton therapy. The first proton therapy equipment was installed in Taiwan in 2017, and several proton centers are proposed to be established in the North, Central, and South of Taiwan in the next few years. This article summarizes the available literature on proton therapy, reviews the therapeutic effectiveness in head and neck cancer, and serves as a reference for the future applications of proton therapy in Taiwan.

Topic Category 醫藥衛生 > 醫藥衛生綜合
Reference
  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
    連結:
  2. Catton C, O'Sullivan B, Bell R, et al. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 1996;41:67-72.
    連結:
  3. Alahmari M, Temel Y. Skull base chordoma treated with proton therapy: A systematic review. Surg Neurol Int 2019;10:96.
    連結:
  4. Zhou J, Yang B, Wang X, et al. Comparison of the effectiveness of radiotherapy with photons and particles for chordoma after surgery: a meta-analysis. World Neurosurg 2018;117: 46-53.
    連結:
  5. Rosenberg AE, Nielsen GP, Keel SB, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999;23:1370-8.
    連結:
  6. Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol 2014;15:1027-38.
    連結:
  7. Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol 2014;110:398-403.
    連結:
  8. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-9.
    連結:
  9. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-91.
    連結:
  10. Taheri-Kadkhoda Z, Björk-Eriksson T, Nill S, et al. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol 2008;3:4.
    連結:
  11. Chan A, Adams J, Weyman E, et al. A phase II trial of proton radiation therapy with chemotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2012;84:S151-2.
    連結:
  12. Lewis GD, Holliday EB, Kocak–Uzel E, et al. Intensity‐modulated proton therapy for nasopharyngeal carcinoma: decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck 2016; 38:E1886-95.
    連結:
  13. Holliday EB, Garden AS, Rosenthal DI, et al. Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy. Int J Part Ther 2015;2:19-28.
    連結:
  14. Vokes EE, Agrawal N, Seiwert TY. HPV-associated head and neck cancer. J Natl Cancer Inst 2015;107: djv344.
    連結:
  15. van de Water TA, Lomax AJ, Bijl HP, et al. Potential benefits of scanned intensity- modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011;79:1216-24.
    連結:
  16. Gunn GB, Blanchard P, Garden AS, et al. Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 2016; 95: 360-7.
    連結:
  17. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004;15: 1179-86.
    連結:
  18. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350: 1945-52.
    連結:
  19. Dionisi F, Fiorica F, D'Angelo E, et al. Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review. Oral Oncol 2019;98:35-47.
    連結:
  20. Phan J, Sio TT, Nguyen TP, et al. Reirradiation of head and neck cancers with proton therapy: outcomes and analyses. Int J Radiat Oncol Biol Phys 2016;96: 30-41.
    連結:
  21. Romesser PB, Cahlon O, Scher ED, et al. Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes. Int J Radiat Oncol Biol Phys 2016;95: 386-95.
    連結:
  22. Lundkvist J, Ekman M, Ericsson SR, et al. Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncologica 2005;44:850-61.
    連結:
  23. Pijls-Johannesma M, Pommier P, Lievens Y. Cost-effectiveness of particle therapy: current evidence and future needs. Radiotherapy Oncol 2008; 89: 127-134.
    連結:
  24. Blanchard P, Gunn GB, Lin A, et al. Proton therapy for head and neck cancers. Semin Radiat Oncol 2018;28:53-63.
    連結:
  25. Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer 2016;122:1483-501.
    連結:
  26. Zhang Y, Boye D, Tanner C, et al. Respiratory liver motion estimation and its effect on scanned proton beam therapy. Phys Med Biol 2012;57: 1779.
    連結:
  27. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21.
    連結:
  28. Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol 2014;59:R419-472.
    連結:
  29. Leeman JE, Romesser PB, Zhou Y, et al. Proton therapy for head and neck cancer: expanding the therapeutic window. Lancet Oncol 2017;18: e254-e265.
    連結:
  30. Ahn PH, Lukens JN, Teo B-KK, et al. The use of proton therapy in the treatment of head and neck cancers. Cancer J 2014;20:421-6.
    連結:
  31. Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncolo Biol Phys 2014;89:292-302.
    連結: